QA: Chinook Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2018_Chinook_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001435049, Chinook Therapeutics INC

  xvar xval
0 AssetsCurrent 350,131,000
1 IntangibleAssetsNetIncludingGoodwill 39,830,000
2 PropertyPlantAndEquipmentNet 31,085,000
3 remainder_Assets 24,082,000
4 LiabilitiesCurrent 41,401,000
5 LiabilitiesNoncurrent 818,000
6 remainder_Liabilities 165,436,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 33,751,000
9 ResearchAndDevelopmentExpense 89,382,000
10 remainder_Expenses -10,805,000
11 remainder_Revenues 17,239,000
12 remainder_NetIncome 3,226,000
13 remainder_ComprehensiveNetIncome 3,577,000
  yvar yval
0 Assets 445,128,000
1 Liabilities 207,655,000
2 Expenses 112,328,000
3 Revenues 17,239,000
4 StockholdersEquity 237,473,000
5 NetIncome -91,863,000
6 ComprehensiveNetIncome -90,074,500
7 BaseVar 394,576,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.31
9 EconomicCapitalRatio 2.54

Edgar->Model Mapping

Feature Distribution

Change over Time